Key Market Indicators
Luxembourger analgesic medicine sales are expected to hit $13 million by 2026. In 2021, the country was ranked 22nd, with sales of $12 million. Latvia held the top spot at $12 million. Spain, Canada and Italy followed in second, third and fourth place. Since 2000, analgesic medicine sales in Luxembourg have increased by an average of 7% annually.
